The Unknown Impacts of Combinations of Large Numbers of Drugs Ronald N. KostoffJeffrey C. Delafuente Editorial 20 November 2012 Pages: 183 - 185
Bill Inman: Drug Safety Physician and Pharmacoepidemiologist Saad A.W. Shakir In Memory 20 November 2012 Pages: 187 - 188
A Preliminary Benefit-Risk Assessment of Verteporfin in Age-Related Macular Degeneration Jason WickensKevin J. Blinder Review Article 20 November 2012 Pages: 189 - 199
Safety and Tolerability of the Antibacterial Rifaximin in the Treatment of Travellers’ Diarrhoea Charles D. Ericsson Review Article 20 November 2012 Pages: 201 - 207
Camptothecin and Podophyllotoxin Derivatives Jörg T HartmannHans-Peter Lipp Review Article 20 November 2012 Pages: 209 - 230
Continuation of Amiodarone Therapy Despite Type II Amiodarone-Induced Thyrotoxicosis Laurent UzanLaurence GuignatDenis Duboc Short Communication 20 November 2012 Pages: 231 - 236
Evaluation of the Rabbit Purkinje Fibre Assay as an in vitro Tool for Assessing the Risk of Drug-Induced Torsades de Pointes in Humans Marion AubertRolf OsterwalderEric A. Ertel Original Research Article 20 November 2012 Pages: 237 - 254
Early First-Trimester Sibutramine Exposure Marco De SantisGianluca StrafaceAlessandro Caruso Original Research Article 20 November 2012 Pages: 255 - 259
Cardiovascular Events Associated with Long-Term Use of Celecoxib, Rofecoxib and Meloxicam in Taiwan Weng-Foung HuangFei-Yuan HsiaoYaw-Tang Shih Original Research Article 20 November 2012 Pages: 261 - 272
Extension of Points on Clarifying Terminology in Drug Safety Manfred HaubenLester ReichFlic Gabbay Correspondence 20 November 2012 Pages: 273 - 275